EUVIMEDEUVIMED entdecken
Crossref

Nitrated T cell epitope linked vaccine targeting CD47 elicits antitumor immune responses and acts synergistically with vaccine targeting PDL1

Danni Deng, Guozhi Li, Xuefei Xia, Shuyang Xu, Le Gao, Li Zhang, Wenbing Yao, Hong Tian, Xiangdong Gao

International Immunopharmacology · 2024-02 · 128 · 111374

DOI: 10.1016/j.intimp.2023.111374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-02. Verfasst von Danni Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, Ch…. Hauptthemen laut MEDLINE: Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Double First Class University Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the clinical breakthrough made by immune checkpoint blockades (ICB) in cancer immunotherapy, immunosuppressed tumor microenvironment (TME) remains a major impediment in the efficacy of ICB immunotherapy. In this study, we constructed a Nitrated T cell epitope (NitraTh) linked vaccine targeting CD47, namely CD47-NitraTh. CD47-NitraTh could repress the progression of tumor by inducing tumor-specific immune response. Furthermore, combination vaccination with CD47-NitraTh and PDL1-NitraTh could reconstruct tumor associated macrophage, enhance macrophage-mediated phagocytosis for tumor cells, and promote the activation of tumor infiltrating T cells. Notably, by activating chemokine signaling pathway, NitraTh based vaccines reversed immunosuppressed TME, resulting in improved therapeutic outcome for tumor. With the advantage of reversing immunosuppressed TME, NitraTh based vaccine seems an optimal immunotherapy strategy for patients who are not sensitive to antibody based ICB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCancer VaccinesHumansCD47 AntigenEpitopes, T-LymphocyteImmunotherapyNitratesPhagocytosisTumor Microenvironment

Stichwörter der Autor:innen

CD47Cancer ImmunotherapyNitrated T cell epitopePDL1Therapeutic Vaccine

Substanzen

CD47 AntigenCD47 protein, humanEpitopes, T-LymphocyteNitratesCancer Vaccines

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China; Dep…
  • Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China.
  • Department of General Internal Medicine, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uyghur Autonomous Region, 830054, PR China.
  • Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, 210009, PR China. Ele…

Förderung

  • National Natural Science Foundation of China
  • Double First Class University Plan

Zitieren

APA

Deng, D., Li, G., Xia, X., Xu, S., Gao, L., Zhang, L., Yao, W., Tian, H., & Gao, X. (2024). Nitrated T cell epitope linked vaccine targeting CD47 elicits antitumor immune responses and acts synergistically with vaccine targeting PDL1. International Immunopharmacology, 128, 111374. https://doi.org/10.1016/j.intimp.2023.111374

Vancouver

Deng D, Li G, Xia X, Xu S, Gao L, Zhang L, et al. Nitrated T cell epitope linked vaccine targeting CD47 elicits antitumor immune responses and acts synergistically with vaccine targeting PDL1. International Immunopharmacology. 2024;128:111374. doi:10.1016/j.intimp.2023.111374

BibTeX
@article{Deng2024,
  author = {Deng, Danni and Li, Guozhi and Xia, Xuefei and Xu, Shuyang and Gao, Le and Zhang, Li and Yao, Wenbing and Tian, Hong and Gao, Xiangdong},
  title = {Nitrated T cell epitope linked vaccine targeting CD47 elicits antitumor immune responses and acts synergistically with vaccine targeting PDL1},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {128},
  pages = {111374},
  doi = {10.1016/j.intimp.2023.111374}
}
Kostenlos starten →